North America HLA Typing Market (2025-2030)
The North America HLA Typing Market was valued at $579.4 Million in 2025 and projected to reach to $800.5 Million by 2030, representing a compound annual growth rate of 6.7%. The North America HLA typing market is positioned for steady expansion, growing from $579.4 million in 2025 to $800.5 million by 2030 at a 6.7% CAGR, outpacing the global growth rate of 6%.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America HLA Typing Market Trends and Insights
- North America's advanced healthcare infrastructure, high adoption of precision medicine, and strong investment in transplantation programs drive demand for HLA typing solutions.
- The region benefits from established diagnostic laboratories, regulatory support, and a growing patient population requiring organ and stem cell transplants. In North America, the HLA typing market is supported by increasing awareness of immunogenicity testing and the rising prevalence of chronic diseases necessitating transplantation.
- North America's leading position in healthcare innovation and reimbursement frameworks accelerates market expansion through 2030.
- The region's focus on reducing transplant rejection rates and improving patient outcomes continues to fuel adoption of advanced HLA typing technologies across hospitals, diagnostic centers, and research institutions..
Key Market Statistics
- CAGR (2025-2030) 6.7% CAGR
- Market Size, 2025 ~USD 579.4 Million
- Forecast, 2030 ~USD 800.5 Million
- Geography North America
North America HLA Typing Market Overview
Market Leadership :
North America commands the largest share of the global HLA typing market, driven by the US market valued at $1,042.9 million, establishing the region as the industry's primary growth engine and innovation hub.
Advanced Healthcare Infrastructure :
The region's sophisticated diagnostic laboratories, state-of-the-art transplantation centers, and robust reimbursement frameworks accelerate HLA typing adoption across organ transplantation and disease management applications.
Precision Medicine Integration :
North America's strong emphasis on personalized medicine and genomic testing integration drives demand for HLA typing in immunotherapy, pharmacogenomics, and precision oncology applications.
Investment in Transplantation Programs :
Substantial government and private sector investment in organ transplantation networks, coupled with high transplant volumes, creates sustained demand for HLA typing solutions across the region.
North America HLA Typing Market Dynamics
- This acceleration is fueled by increasing organ transplant procedures, rising adoption of HLA-based immunotherapy protocols, and expanding applications in disease susceptibility screening.
- The region's mature healthcare ecosystem and strong regulatory support enable rapid technology adoption and market penetration. Key growth drivers include the integration of HLA typing into precision medicine frameworks, growing awareness of HLA-related adverse drug reactions, and expanding clinical applications beyond transplantation.
- North America's leadership in research and development, combined with favorable reimbursement policies and high healthcare spending, positions the region for sustained market growth through 2030..
Related Ecosystem
Key Takeaways
- North America's HLA typing market is valued at $579.4 million in 2025 and will reach $800.5 million by 2030, growing at 6.7% CAGR.
- North America leads in HLA typing adoption due to advanced healthcare infrastructure and high transplantation volumes.
- Precision medicine initiatives and immunogenicity awareness are key growth drivers in North America.
- North America's strong regulatory environment and reimbursement support accelerate market expansion through 2030.
HLA Typing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | COMMERCIAL SERVICE PROVIDERS (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | DIAGNOSTIC APPLICATIONS (Application) |
| Market Size Base Year (Billions) | ~USD 1.72 (2025) |
| Revenue Forecast (Billions) | ~USD 2.3 (2030) |
| Segments Covered | Product & Service, Technology, Type, Application, End User, Diagnostic Application |
North America HLA Typing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents & Consumables
- Software & Services
By Technology
- Molecular Assay Technologies
- Non-Molecular Assay Technologies
By Type
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Next-Generation Sequencing
- Other Diagnostic Applications
- Other Pcr-Based Molecular Assays
- Other Sequencing-Based Molecular Assays
- Pcr-Based Molecular Assays
- Real-Time Pcr
- Sanger Sequencing
- Sequence-Specific Oligonucleotide-Pcr
- Sequence-Specific Primar-Pcr
- Sequence-Specific Primer-Pcr
- Sequencing-Based Molecular Assays
- Transfusion Therapy
By Application
- Diagnostic Applications
- Research Applications
By End User
- Commercial Service Providers
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
By Diagnostic Application
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Other Diagnostic Applications
- Transfusion Therapy
Target Audience
- Diagnostic Laboratory Operators : Need market sizing and growth forecasts to justify investments in HLA typing infrastructure, equipment upgrades, and staffing expansion across North American diagnostic networks.
- Medical Device & IVD Manufacturers : Require regional market data to develop go-to-market strategies, identify distribution partnerships, and allocate R&D resources for HLA typing assay development and commercialization.
- Transplantation Program Directors : Seek insights on HLA typing adoption trends, best practices, and market innovations to optimize transplant outcomes, improve operational efficiency, and justify budget allocations.
- Healthcare Investors & Private Equity : Need comprehensive market analysis, growth projections, and competitive intelligence to evaluate investment opportunities in HLA typing companies and diagnostic service providers.
- Pharmaceutical & Biotech Companies : Require data on HLA typing integration in immunotherapy and precision medicine to inform clinical trial design, patient stratification strategies, and companion diagnostic development.
Key Companies in the North America HLA Typing Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BGI GENOMICS | China | Public Company | Sequencing-based HLA services (NGS, immune repertoire, WES/WGS-derived typing),Reagents & consumables for HLA workflows,Instruments (sequencers and related hardware used for HLA), |
| BECTON DICKINSON AND CO | United States | Public Company | Instruments,Reagents,Software, |
| BD | United States | Public Company | Instruments,Reagents,Software, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Sequencing-based HLA (NGS, Sanger),PCR-based HLA (SSO, SSP, Real-time),Software and Informatics, |
| ILLUMINA, INC. | United States | Public Company | Sequencing Instruments (NGS platforms used for HLA typing),Sequencing Reagents, Flow Cells, and Library Prep for HLA,Software and DRAGEN-based Secondary Analysis for HLA, |
| QIAGEN | Netherlands | Public Company | Reagents & Consumables (PCR, NGS, sample technologies for HLA workflows),Instruments (PCR, NGS-related, automation, QC),Software & Bioinformatics (HLA analysis, SaaS, interpretation), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Reagents & Consumables (PCR and sequencing HLA kits),Instruments (PCR, sequencing-adjacent, and automation),Software & Informatics (HLA analysis, LIS connectivity), |
| F. HOFFMANN-LA ROCHE LTD | United States | ||
| CAREDX, INC. | United States | Public Company | HLA Typing Reagents & Assays (PCR SSO/SSP, Real-time, NGS, Sanger),Instruments & NGS Workflow Components,Software (Ottr, HLA Data Systems, XynQAPI, MedActionPlan, others), |
| DIASORIN S.P.A. | Italy | Public Company | Instruments,Reagents,Software, |
| EUROBIO SCIENTIFIC | France | Public Company | Reagents (PCR and NGS HLA typing),Software (HLA typing analysis and reporting),Instruments (sequencers, ancillary lab systems), |
BGI GENOMICS
BGI Genomics is a Chinese public company founded in 1999 that employs 3,580 people. The company operates in the genomics and genetic sequencing sector.
BECTON DICKINSON AND CO
Becton Dickinson and Co is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
BD
BD is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company operates in the life sciences and diagnostics industry.
ILLUMINA, INC.
Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. The company specializes in DNA sequencing and genetic analysis technologies.
QIAGEN
QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company operates in the molecular diagnostics and life sciences sector.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.
F. HOFFMANN-LA ROCHE LTD
Insufficient data available to provide a business description for this company.
CAREDX, INC.
CareDx, Inc. is a United States-based public company founded in 1998 with 763 employees. The company operates in the molecular diagnostics and transplant monitoring sector.
DIASORIN S.P.A.
DiaSorin S.p.A. is an Italy-based public company founded in 1968 with 3,242 employees. The company specializes in diagnostic solutions and immunoassay products.
EUROBIO SCIENTIFIC
Eurobio Scientific is a France-based public company founded in 1997 with 343 employees. The company operates in the life sciences and diagnostics industry.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 1042.9 Million |
| Canada | USD 44.63 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Dominance Data : Gain comprehensive insights into North America's $579.4M market with country-level breakdowns for the US ($1,042.9M) and Canada ($44.63M), enabling precise market positioning and competitive benchmarking.
- Growth Trajectory & Forecasting : Access detailed 5-year projections showing 6.7% CAGR growth to $800.5M by 2030, supporting strategic planning, investment decisions, and resource allocation for market expansion.
- Transplantation Market Insights : Understand the region's advanced transplantation infrastructure and high procedure volumes driving HLA typing demand, identifying opportunities in organ procurement networks and transplant centers.
- Precision Medicine Integration Trends : Leverage data on North America's leadership in precision medicine adoption, immunotherapy applications, and pharmacogenomics integration to identify emerging market segments and innovation opportunities.
- Competitive Landscape Analysis : Benchmark against regional market leaders and understand the regulatory environment, reimbursement policies, and healthcare infrastructure advantages that shape competitive dynamics in North America.
Frequently asked questions
What is the current size of the HLA typing market in North America?
The North America HLA typing market is valued at $579.4 million in 2025 and is expected to grow to $800.5 million by 2030.
What is the projected growth rate for HLA typing in North America?
North America's HLA typing market is projected to grow at a compound annual growth rate of 6.7% from 2025 to 2030.
What factors drive HLA typing demand in North America?
North America's demand for HLA typing is driven by advanced healthcare infrastructure, high transplantation volumes, precision medicine adoption, and strong reimbursement frameworks.
Which applications dominate the North America HLA typing market?
Organ transplantation, stem cell transplantation, and immunogenicity testing are the primary applications driving North America's HLA typing market growth.
How does North America's HLA typing market compare globally?
North America represents a significant portion of the global HLA typing market, with higher adoption rates and advanced diagnostic capabilities compared to other regions.
RESEARCH METHODOLOGY
This research study extensively utilized secondary sources, directories, and databases to identify and gather valuable information for analyzing the global HLA typing market. Additionally, in-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives from leading market players, and industry consultants. These interviews helped obtain and validate critical qualitative and quantitative data while assessing the growth prospects. The global market size, initially estimated through secondary research, was then refined and finalized through triangulation with insights from primary research.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the HLA typing market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various companies and organizations in the HLA typing market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The bottom-up approach was used to estimate and validate the total size of the HLA typing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- A list of the major global players operating in the HLA typing market was generated.
- Mapping annual revenues generated by major global players from the HLA typing segment (or nearest reported business unit/service category)
- Revenue mapping of key players to cover a major share of the global market as of 2024
- Extrapolating the global value of the HLA Typing industry
Global HLA Typing Market Size: Bottom-up Approach and Top-down Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
HLA typing is a genetic procedure to determine donor-recipient compatibility, cancer & autoimmune disorder diagnosis, pathogen testing, and transfusion therapy. Additionally, it is used in drug testing, disputed paternity, and anthropological studies. Advanced genomic techniques, such as PCR and NGS, are increasingly being used in HLA typing, apart from serological and other conventional techniques for immuno-compatibility testing.
Stakeholders
- HLA Typing Product Manufacturers
- Healthcare Service Providers (Hospitals, Transplant Centers, and Blood Transfusion Centers)
- Blood, Tissue, and Stem Cell Banks
- Government Organizations
- Independent Associations and Regulatory Authorities
- R&D Companies
- Independent Reference Laboratories
- Diagnostic Laboratories
- Clinical Research Organizations
- Research Laboratories and Academic Institutes
Report Objectives
- To define, describe, and forecast the HLA typing market based on technology, product & service, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global HLA typing market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global HLA typing market
- To analyze key growth opportunities in the global HLA typing market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa (GCC Countries and Rest of Middle East & Africa)
- To profile the key players in the HLA typing market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global HLA typing market, such as agreements, expansions, and acquisitions
Get the Full HLA Typing Market Report
Full forecast, segment splits, and company analysis for all HLA Typing Market.
- Canada HLA Typing Market
- US HLA Typing Market
- Germany HLA Typing Market
- UK HLA Typing Market
- France HLA Typing Market
- Spain HLA Typing Market
- Italy HLA Typing Market
- China HLA Typing Market
- Japan HLA Typing Market
- India HLA Typing Market
- South Korea HLA Typing Market
- Australia HLA Typing Market
- Brazil HLA Typing Market
- Mexico HLA Typing Market
- Rest Of Europe HLA Typing Market
- Rest Of Asia HLA Typing Market
- Rest Of Latin America HLA Typing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
